Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · IEX Real-Time Price · USD
23.35
-0.67 (-2.79%)
At close: Dec 29, 2023, 4:00 PM
23.42
+0.07 (0.30%)
After-hours: Dec 29, 2023, 7:49 PM EST
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $1.30 billion as of December 29, 2023. Its market cap has decreased by -38.38% in one year.
Market Cap
1.30B
Enterprise Value
771.82M
1-Year Change
-38.38%
Ranking
Category
Stock Price
$23.35
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $481.70M to $1.30B, an increase of 170.05%. That is a compound annual growth rate of 24.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 29, 2023 | 1.30B | -2.79% |
Dec 28, 2023 | 1.34B | -0.95% |
Dec 27, 2023 | 1.35B | 2.24% |
Dec 26, 2023 | 1.32B | 2.77% |
Dec 22, 2023 | 1.29B | 3.41% |
Dec 21, 2023 | 1.24B | 3.52% |
Dec 20, 2023 | 1.20B | -6.62% |
Dec 19, 2023 | 1.29B | 5.00% |
Dec 18, 2023 | 1.23B | -4.01% |
Dec 15, 2023 | 1.28B | 2.65% |
Dec 14, 2023 | 1.24B | 9.73% |
Dec 13, 2023 | 1.13B | 2.93% |
Dec 12, 2023 | 1.10B | 1.59% |
Dec 11, 2023 | 1.08B | -2.11% |
Dec 8, 2023 | 1.11B | 0.51% |
Dec 7, 2023 | 1.10B | 3.73% |
Dec 6, 2023 | 1.06B | 4.04% |
Dec 5, 2023 | 1.02B | 2.29% |
Dec 4, 2023 | 997.80M | 1.42% |
Dec 1, 2023 | 983.80M | 5.49% |
Nov 30, 2023 | 932.60M | 0.48% |
Nov 29, 2023 | 928.10M | 0.85% |
Nov 28, 2023 | 920.30M | 2.61% |
Nov 27, 2023 | 896.90M | -1.47% |
Nov 24, 2023 | 910.30M | 2.51% |
View and export this data all the way back to 2019.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vir Biotechnology | 1.35B |
Avadel Pharmaceuticals | 1.34B |
Protagonist Therapeutics | 1.32B |
UFP Technologies | 1.31B |
Sage Therapeutics | 1.30B |
Deciphera Pharmaceuticals | 1.29B |
Xencor | 1.29B |
Aurinia Pharmaceuticals | 1.29B |